Lexicon Pharmaceuticals, Inc. Gains 41.75%
Tue, Jul 05, 2022 at 08:30 PM
Lexicon Pharmaceuticals, Inc. (LXRX:NASDAQ) rocketted at $2.75, a gain of 41.8%. On Tue, Jul 05, 2022, LXRX:NASDAQ hit a New 2-Week High of $2.75. The stock got featured on our News Catalysts scanner on Wed, Jun 29, 2022 at 07:01 PM in the 'BIOTECH' category. From Tue, Jun 21, 2022, the stock recorded 77.78% Up Days and 80.00% Green Days
About Lexicon Pharmaceuticals, Inc. (LXRX:NASDAQ)
Lexicon Pharmaceuticals Inc operates as a biopharmaceutical company engaged in discovery and development of breakthrough treatments for human disease. The company mainly designs and develops drugs for therapeutic areas.
Top 10 Gainers:
- Enjoy Technology Inc. (ENJY:NASDAQ), 81.5%
- Rubicon Technology, Inc. (RBCN:NASDAQ), 66.11%
- Faraday Future Intelligent Electric Inc. (FFIE:NASDAQ), 48.73%
- Nuwellis Inc. (NUWE:NASDAQ), 48.51%
- Agrico Acquisition Corp. (RICO:NASDAQ), 43.66%
- Lexicon Pharmaceuticals, Inc. (LXRX:NASDAQ), 41.75%
- ChinaNet Online Holdings, Inc. (CNET:NASDAQ), 40.85%
- Avadel Pharmaceuticals plc (AVDL:NASDAQ), 40.08%
- AGM Group Holdings Inc. (AGMH:NASDAQ), 39.83%
- Ra Medical Systems, Inc. (RMED:NYSE), 39.19%